Home » PDL BioPharma Sells Minnesota Facility for $240 Million
PDL BioPharma Sells Minnesota Facility for $240 Million
PDL BioPharma Inc. sold its Brooklyn Park, Minn., antibody manufacturing facility to Genmab A/S of Denmark, the latest asset-shedding move by the company.
East Bay Business Times
East Bay Business Times
Upcoming Events
-
07May
-
14May
-
30May